EZBrisk / Market Verdict

UBS upgrade lifts TMO

Thermo Fisher is climbing moderately on a fresh analyst upgrade to Buy with a raised price target, offsetting some early weakness tied to its approaching dividend date.

Sources: https://goldesel.de/aktien/news/thermo-fisher-aktie-ubs-hebt-rating-auf-buy-und-kursziel-auf-730-us-dollar, https://www.investing.com/news/analyst-ratings/4892913, https://www.benzi

Previous verdicts for TMO

Sources

[1][2][3]

Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works

Open the live Ezbrisk dashboard Browse the archive